Data
Lookout
Search
Browse
Diseases
Sponsors
Pipeline Pulse
Weekly Report
Watchlist
Blog
Pricing
Sign In
Home
NCT06974669
Clinical Trial
The Value of Using Mini-oral Pulse Steroid Therapy Along With Non Cultured Epidermal Cell Suspension (NCES) in Stable Resistant Vitiligo
Study acronym:
NCES
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 16, 2025 (before its estimated August 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
Assessing the additive value of mini-oral pulse steroid therapy in surgical treatment of acral and difficult to treat sites of vitiligo
Trial Details
NCT Number
NCT06974669
Lead Sponsor
Cairo University
Conditions
Vitiligo
Enrollment
40 participants
Start Date
2025-05-12
Primary Completion
2025-08-15
(estimated)
Study Completion
2025-10-01
(estimated)
Updated on ClinicalTrials.gov
2025-05-16